Conference Coverage

Chelation plus vitamins halved cardiovascular events in diabetics


 

AT THE AHA SCIENTIFIC SESSIONS

In addition, in diabetic patients the formation of advanced glycation endpoints requires catalytic activity by metals in order to create oxygen species and cross linkage, he continued.

The TACT trial was sponsored by the National Center for Complementary and Alternative Medicine and the National Heart, Lung, and Blood Institute. Dr. Lamas reported having no relevant financial interests.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Study hints at obesity paradox in older women with coronary artery disease
MDedge Endocrinology
Inherently low triglycerides may lower mortality
MDedge Endocrinology
CV outcomes data needed to expand approval of TG-lowering agent
MDedge Endocrinology
Hunting for cardiovascular signals from diabetes drugs
MDedge Endocrinology
‘Substantial’ weight loss seen 3 years after bariatric surgery
MDedge Endocrinology
FDA moves to reduce or remove unhealthy trans fats from foods
MDedge Endocrinology
ACC-AHA cardiovascular prevention guidelines drop cholesterol treatment goals
MDedge Endocrinology
Abandon LDL targets? Not yet
MDedge Endocrinology
Guideline authors, AHA-ACC leaders confident in risk calculator
MDedge Endocrinology
FDA lifts rosiglitazone prescribing restrictions
MDedge Endocrinology